Advantages Of Our Expertise In Proprietary Cell Lines

A reliable and efficient cell line forms the foundation of successful biologics manufacturing, particularly for vaccines, gene therapies, and oncolytic viruses. Our proprietary cell lines are supported by extensive expertise in adherent cell culture across multiple scales, from flasks to microcarriers and fixed-bed systems. These well-established platforms offer significant advantages, including reduced development costs, fewer regulatory hurdles, and faster project timelines. Because no third-party licensing is required and existing master and working cell banks are available, early-stage programs benefit from both financial and operational efficiency. With built-in regulatory support and proven performance, these cell lines enable a smoother path to commercialization. Discover how our cell line platforms can help accelerate your next breakthrough.